Article
Second Circuit Declares Off-Label Promotion Ban Unconstitutional: Implications For False Claims Act Defendants
On December 3, 2012, the United States Court of Appeals for the Second Circuit held that the First Amendment protects pharmaceutical companies who truthfully promote the lawful, off-label use of prescription drugs from criminal prosecution in United States v. Caronia, __ F. 3d ___, 2012 WL 5992141 (2d Cir. Dec. 3, 2012).
Patterson Belknap Webb & Tyler LLP





